Gerresheimer Q2 2026 adjusted EBITDA jumps 52% q/q to EUR 102 million; revenue rises 11% q/q to EUR 578 million

By Public Technologies
  • Gerresheimer posted preliminary Q2 2026 revenue of EUR 578 million, up 11% from Q1’s EUR 523 million.
  • Adjusted EBITDA climbed to EUR 102 million, up 52% from Q1’s EUR 67 million, while the adjusted EBITDA margin widened 5.0 percentage points to 17.6%.
  • First-half revenue slipped 4% to EUR 1.10 billion, and adjusted EBITDA fell 25% to EUR 168 million.
  • Containment & Delivery Systems rose to EUR 604 million in first-half revenue, while Primary Injectable Solutions dropped to EUR 212 million.
  • Management flagged a stronger second half, with preparations for closing the Centor sale in the final stages.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gerresheimer AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2407490_en) on September 30, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.